Drug Profile
P 53
Alternative Names: P53Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Phytopharm
- Class Antipruritics; Antipsoriatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pruritus; Psoriasis
Most Recent Events
- 01 Feb 2000 No-Development-Reported for Psoriasis in United Kingdom (Topical)
- 10 Dec 1998 Phase-II clinical trials for Pruritus in United Kingdom (Topical)
- 12 Feb 1998 Phase-II clinical trials for Psoriasis in United Kingdom (Topical)